ESH Acquisition Corp Right
ESHAR
ESHAR was delisted on the 30th of April, 2026.
22 hedge funds and large institutions have $1.08M invested in ESH Acquisition Corp Right in 2026 Q1 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 3 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 22 → 22 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
47% less capital invested
Capital invested by funds: $2.04M → $1.08M (-$963K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$1.57K |
| 2 |
CS
Clear Street
New York
|
+$539 |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$515 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$859 |
| 2 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
-$539 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2 |
ESHAR Hedge Fund Activity: Q1 2026 in Review
22 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in ESH Acquisition Corp Right (ESHAR) for Q1 2026, worth a combined $1.08M — down 47% from $2.04M a quarter earlier.
Fund positioning in ESHAR was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Highbridge Capital Management, adding an estimated $1.57K. The largest seller was K2 Principal Fund, cutting an estimated $859.
- 22 institutional investors held ESH Acquisition Corp Right (ESHAR) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $1.08M of ESH Acquisition Corp Right stock for Q1 2026, down 47% quarter-over-quarter.
- 0 funds opened new ESH Acquisition Corp Right positions in Q1 2026 and 0 closed out.
- The largest ESH Acquisition Corp Right buyer in Q1 2026 was Highbridge Capital Management, an estimated $1.57K added.
- The largest ESH Acquisition Corp Right seller in Q1 2026 was K2 Principal Fund, an estimated $859 sold.
Based on aggregated 13F filings for Q1 2026.